Abstract 282P
Background
Multiple Myeloma (MM) is second most common hematological malignancy characterized by uncontrolled proliferation of abnormal plasma cells in bone marrow. microRNAs are newly emerged nowadays for their involvement in post-transcriptional regulation of certain genes. Earlier, we reported overexpression of an extracellular matrix protein, Versican (VCAN) in MM especially in the stroma but its involvement in disease pathogenesis has not been reported yet. Hence, we studied the role of VCAN via its regulation by microRNAs on myeloma pathogenesis.
Methods
The molecular expression of VCAN was investigated in myeloma cell lines (RPMI8226 & U266). The antagomirs of microRNAs (miR-144 and miR-199) were then transfected into myeloma cells to investigate the effect on VCAN expression along with the effect on proliferation, apoptosis, migration and invasion of myeloma cells. In addition, signaling pathways affected by the inhibition of miR-144 and miR-199 were also identified. The functional regulation of VCAN by miR-144 and miR-199 was also confirmed by reporter luciferase assay in which VCAN 3’UTR was transfected to the myeloma cells.
Results
The expression of VCAN was found at minimal level in both the myeloma cells. The transfection of antagomirs of miR-144 and miR-199 significantly enhanced the transcript and protein levels of VCAN in myeloma cells. Further, myeloma cells parameters found to be altered in favor of disease progression such as cell proliferation, migration and invasion increased with simultaneous inhibition of apoptosis. In addition, antagomirs mediated upregulation of VCAN promote myeloma progression via activation of FAK/STAT3 signaling. Moreover, transfection of wild type VCAN 3’UTR resulted in significant decrease in luciferase activity which got restored by mutating the binding site of microRNAs.
Conclusions
miR-144 and mir-199 antagomirs mediated over-expression of VCAN promoted the myeloma pathogenesis in vitro with downstream activation of FAK and STAT3 signaling. These findings, therefore, affirm the translational importance of microRNAs which could be adopted as a mean for targeting VCAN and might emerge as an effective therapy for better management of MM in clinical settings in future.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
AIIMS, New Delhi, India.
Funding
All India Institute of Medical Sciences, Council of Scientific and Industrial Research.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
143P - NOTCH3 expression predicts poor survival in advanced esophageal squamous cell cancers
Presenter: Raja Pramanik
Session: Poster display session
Resources:
Abstract
144P - Severe hypovitaminosis D in metastatic gastric cancer patients from the Northern and Southern hemispheres: Data from the EXPAND phase III trial
Presenter: Radka Obermannova
Session: Poster display session
Resources:
Abstract
145P - Role of Glasgow prognostic score in chemo-naïve patients with advanced biliary tract cancer and good performance status
Presenter: Toshikazu Moriwaki
Session: Poster display session
Resources:
Abstract
146P - Anatomic versus non-anatomic resection for hepatocellular carcinoma: A meta-analysis of high-quality studies
Presenter: Bin Zhang
Session: Poster display session
Resources:
Abstract
147P - Clinical outcomes of proximal gastrectomy versus total gastrectomy for locally advanced proximal gastric cancer: a propensity score matching analysis
Presenter: Yingtai Chen
Session: Poster display session
Resources:
Abstract
148P - Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
Presenter: Seunghwan Lee
Session: Poster display session
Resources:
Abstract
150P - A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction
Presenter: Yee Chao
Session: Poster display session
Resources:
Abstract
151P - Gene expression profiling for a better understanding of gastric cancer: From the perspective of metabolic rearrangement
Presenter: Midie Xu
Session: Poster display session
Resources:
Abstract
152P - Long-term outcomes of three-dimensional conformal radiotherapy-based and intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal squamous cell carcinoma
Presenter: Chia-Lun Chang
Session: Poster display session
Resources:
Abstract
153P - Exosomal LINC00174 facilitates epithelial-mesenchymal transition in residual hepatocellular carcinoma after insufficient radiofrequency ablation by regulating c-JUN/MYCBP/c-Myc axis
Presenter: Dening Ma
Session: Poster display session
Resources:
Abstract